Loading
Latest filing published 10 Aug 2023 for Vincerx Pharma, Inc., €4,325. Read the official filing
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
All filings by Tom C. Thomas on record concern Vincerx Pharma, Inc. The record holds 4 filings, for trades running from 29 June 2021 to 10 August 2023.
Purchases make up the whole of the open-market record (4 purchases, €40k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2023: 1 purchase and no sales on the market.
The median purchase comes to €7,265. On 4 out of 4 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The newest entry dates from 10 August 2023: an open-market purchase of €4,325, in Vincerx Pharma, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations